SWISS SCIENTISTS, IN COOPERATION WITH THE ROCKEFELLER FOUNDATION AND THE ANGLO-SWEDISH BIOTECH FIRM ASTRA-ZENECA, ARE ONE-STEP CLOSER TO MARKETING THEIR NEWEST BIOTECH INNOVATION, A STRAIN OF RICE WHICH THEY HOPE WILL RID THE WORLD OF BLINDNESS AND MALNUTRITION.
KNOWN MORE POPULARLY AS "GOLDEN RICE", THE NEW PRODUCT IS GENETICALLY ENGINEERED TO PUT A FULL DAY'S WORTH OF VITAMIN "A" AND IRON INTO JUST A FEW SERVINGS.
BIOTECH GIANTS AROUND THE WORLD ARE PLANNING TO MARKET GOLDEN RICE TO THIRD WORLD COUNTRIES WITH OUT DUNNING THEM WITH A TECHNOLOGY FEE.